The NHIS has started negotiations to adjust the drug price increase for the ingredient formulation of the nose cold medicine Pseudoephedrine (PSE), which is struggling with supply and demand. The deadline for this negotiation is 60 days, but it is said to be targeting an agreement this month. If this month's negotiations are signed, it is highly likely that the drug prices raised from next month will be applied. According to the NHIS and the industry on the 18th, the NHIS has been negotiating a drug price adjustment with manufacturers of 60 mg of Pseudoephedrine HCl since last week.

This ingredient was recognized for the validity of the adjustment of the drug price increase by the Pharmaceutical Bene